Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Progepril is a multi-ingredient botanical dietary supplement formulated to manage menstrual cycle irregularities and symptoms of premenstrual syndrome (PMS). It contains extracts of *Dioscorea villosa* (Wild Yam), *Vitex agnus-castus* (Chasteberry), and *Turnera diffusa* (Damiana). The supplement is particularly utilized in women for whom synthetic hormonal treatments are contraindicated, such as breast cancer survivors or individuals with high genetic risk for breast cancer. Its mechanism involves the phyto-progestogenic properties of its components; specifically, *Vitex agnus-castus* contains dopaminergic compounds that bind to pituitary dopamine D2 receptors, leading to a reduction in prolactin secretion and stabilization of the luteal phase. *Dioscorea villosa* provides diosgenin, a plant steroid often associated with progesterone-like effects. Together, these ingredients work to regularize menstrual flow and duration while alleviating psychophysical symptoms associated with the menstrual cycle.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Progepril.